SG11201403540RA - Deuterated thiazolidinone analogues as agonists for follicle stimulating hormone receptor - Google Patents
Deuterated thiazolidinone analogues as agonists for follicle stimulating hormone receptorInfo
- Publication number
- SG11201403540RA SG11201403540RA SG11201403540RA SG11201403540RA SG11201403540RA SG 11201403540R A SG11201403540R A SG 11201403540RA SG 11201403540R A SG11201403540R A SG 11201403540RA SG 11201403540R A SG11201403540R A SG 11201403540RA SG 11201403540R A SG11201403540R A SG 11201403540RA
- Authority
- SG
- Singapore
- Prior art keywords
- agonists
- stimulating hormone
- hormone receptor
- follicle stimulating
- analogues
- Prior art date
Links
- 108010060374 FSH Receptors Proteins 0.000 title 1
- 102000018343 Follicle stimulating hormone receptors Human genes 0.000 title 1
- 239000000556 agonist Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/14—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/42—Gynaecological or obstetrical instruments or methods
- A61B17/425—Gynaecological or obstetrical instruments or methods for reproduction or fertilisation
- A61B17/435—Gynaecological or obstetrical instruments or methods for reproduction or fertilisation for embryo or ova transplantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Transplantation (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261596417P | 2012-02-08 | 2012-02-08 | |
| PCT/EP2013/000215 WO2013117299A1 (en) | 2012-02-08 | 2013-01-24 | Deuterated thiazolidinone analogues as agonists for follicle stimulating hormone receptor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201403540RA true SG11201403540RA (en) | 2014-07-30 |
Family
ID=47666083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201403540RA SG11201403540RA (en) | 2012-02-08 | 2013-01-24 | Deuterated thiazolidinone analogues as agonists for follicle stimulating hormone receptor |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20150111933A1 (en) |
| EP (1) | EP2812320B1 (en) |
| JP (1) | JP6386382B2 (en) |
| KR (1) | KR20140120903A (en) |
| CN (1) | CN104114544A (en) |
| AU (1) | AU2013218368B2 (en) |
| BR (1) | BR112014019351A8 (en) |
| CA (1) | CA2860489C (en) |
| ES (1) | ES2672326T3 (en) |
| HK (1) | HK1201837A1 (en) |
| IL (1) | IL233983B (en) |
| MX (1) | MX2014009416A (en) |
| RU (1) | RU2014136334A (en) |
| SG (1) | SG11201403540RA (en) |
| WO (1) | WO2013117299A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015196335A1 (en) | 2014-06-23 | 2015-12-30 | Tocopherx, Inc. | Pyrazole compounds as modulators of fshr and uses thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6221335B1 (en) * | 1994-03-25 | 2001-04-24 | Isotechnika, Inc. | Method of using deuterated calcium channel blockers |
| CA2339018A1 (en) | 1998-08-07 | 2000-02-17 | Applied Research Systems Ars Holding N.V. | Fsh mimetics for the treatment of infertility |
| US6440710B1 (en) * | 1998-12-10 | 2002-08-27 | The Scripps Research Institute | Antibody-catalyzed deuteration, tritiation, dedeuteration or detritiation of carbonyl compounds |
| US6426357B1 (en) | 1999-07-27 | 2002-07-30 | Affymax, Inc. | Antagonists of follicle stimulating hormone activity |
| PT1104760E (en) * | 1999-12-03 | 2003-06-30 | Pfizer Prod Inc | SULFAMOYL-HETEROARILPIRAZOLE COMPOUNDS AS ANALGESIC AND ANTI-INFLAMMATORY AGENTS |
| JP2004505051A (en) * | 2000-07-27 | 2004-02-19 | スミスクライン ビーチャム コーポレーション | Agonists of follicle stimulating hormone activity |
| TW200413273A (en) * | 2002-11-15 | 2004-08-01 | Wako Pure Chem Ind Ltd | Heavy hydrogenation method of heterocyclic rings |
| CN101309917B (en) * | 2005-10-06 | 2013-09-11 | 奥斯拜客斯制药有限公司 | Deuterated inhibitor of gastric H+, K+-ATPase with enhanced therapeutic properties |
| US7750168B2 (en) * | 2006-02-10 | 2010-07-06 | Sigma-Aldrich Co. | Stabilized deuteroborane-tetrahydrofuran complex |
| EP2209774A1 (en) * | 2007-10-02 | 2010-07-28 | Concert Pharmaceuticals Inc. | Pyrimidinedione derivatives |
| JP2012502038A (en) * | 2008-09-03 | 2012-01-26 | テバ ファーマシューティカル インダストリーズ リミティド | 2-oxo-1,2-dihydro-quinoline modulator of immune function |
| TWI461426B (en) | 2009-05-27 | 2014-11-21 | Merck Sharp & Dohme | (dihydro)imidazoiso[5,1-a]quinolines |
-
2013
- 2013-01-24 BR BR112014019351A patent/BR112014019351A8/en not_active IP Right Cessation
- 2013-01-24 ES ES13702741.3T patent/ES2672326T3/en active Active
- 2013-01-24 AU AU2013218368A patent/AU2013218368B2/en not_active Ceased
- 2013-01-24 WO PCT/EP2013/000215 patent/WO2013117299A1/en not_active Ceased
- 2013-01-24 SG SG11201403540RA patent/SG11201403540RA/en unknown
- 2013-01-24 HK HK15102455.7A patent/HK1201837A1/en unknown
- 2013-01-24 CN CN201380008413.8A patent/CN104114544A/en active Pending
- 2013-01-24 KR KR20147021930A patent/KR20140120903A/en not_active Withdrawn
- 2013-01-24 CA CA2860489A patent/CA2860489C/en not_active Expired - Fee Related
- 2013-01-24 US US14/372,102 patent/US20150111933A1/en not_active Abandoned
- 2013-01-24 RU RU2014136334A patent/RU2014136334A/en unknown
- 2013-01-24 EP EP13702741.3A patent/EP2812320B1/en not_active Not-in-force
- 2013-01-24 MX MX2014009416A patent/MX2014009416A/en unknown
- 2013-01-24 JP JP2014555967A patent/JP6386382B2/en not_active Expired - Fee Related
-
2014
- 2014-08-06 IL IL233983A patent/IL233983B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| IL233983B (en) | 2019-12-31 |
| WO2013117299A1 (en) | 2013-08-15 |
| KR20140120903A (en) | 2014-10-14 |
| JP6386382B2 (en) | 2018-09-05 |
| AU2013218368A1 (en) | 2014-07-17 |
| CA2860489A1 (en) | 2013-08-15 |
| ES2672326T3 (en) | 2018-06-13 |
| US20150111933A1 (en) | 2015-04-23 |
| BR112014019351A8 (en) | 2017-07-11 |
| BR112014019351A2 (en) | 2017-06-20 |
| IL233983A0 (en) | 2014-09-30 |
| HK1201837A1 (en) | 2015-09-11 |
| CN104114544A (en) | 2014-10-22 |
| EP2812320A1 (en) | 2014-12-17 |
| CA2860489C (en) | 2019-11-12 |
| AU2013218368B2 (en) | 2017-09-07 |
| MX2014009416A (en) | 2014-11-10 |
| RU2014136334A (en) | 2016-04-10 |
| EP2812320B1 (en) | 2018-03-07 |
| JP2015511943A (en) | 2015-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL233759A0 (en) | Hormone containing emulsion | |
| PL2806886T3 (en) | Stabilised protein compositions based on semifluorinated alkanes | |
| IL237277B (en) | Anti-prolactin receptor antibody formulations | |
| IL258357A (en) | Semisolid aqueous pharmaceutical composition containing tapentadol | |
| HUE039607T2 (en) | Progesterone antagonists | |
| IL233485A0 (en) | Spiroindoline derivatives as gonadotropin-releasing hormone receptor antagonists | |
| GB201203181D0 (en) | Blade tip timing uncertainty | |
| IL244986A0 (en) | Novel formulation for gonadotropins | |
| IL235740A0 (en) | Somatostatin receptor agonist formulations | |
| ZA201801736B (en) | Progesterone receptor antagonist dosage form | |
| EP2796149A4 (en) | Composition for skin containing silicone base | |
| SG11201403540RA (en) | Deuterated thiazolidinone analogues as agonists for follicle stimulating hormone receptor | |
| IL243730B (en) | Peptides as vasopressin-2 receptor agonists | |
| ZA201508209B (en) | Spiroindoline derivatives for use as gonadotropin-releasing hormone receptor antagonists | |
| SI3079691T1 (en) | Pharmaceutical composition comprising dantrolene as ryanodine receptor antagonist for facilitating wound healing | |
| IL233770A0 (en) | Formylated xanthocillin analogues as neuroprotectants | |
| PT3290029T (en) | Semisolid aqueous pharmaceutical composition containing tapentadol | |
| GB201105108D0 (en) | Wing tip pod |